Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1258206

Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?

Marcec, Robert; Dodig, Vinko Michael; Likic, Robert
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say? // Journal of Infection, 86 (2023), 1; 66-117 doi:10.1016/j.jinf.2022.10.030 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1258206 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?

Autori
Marcec, Robert ; Dodig, Vinko Michael ; Likic, Robert

Izvornik
Journal of Infection (0163-4453) 86 (2023), 1; 66-117

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Regdanvimab ; mortality ; morbidity ; COVID-19 ;

Sažetak
Utjecaj regdanvimaba na morbiditet i mortalitet pacijenata s COVID-19.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Robert Likić (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Marcec, Robert; Dodig, Vinko Michael; Likic, Robert
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say? // Journal of Infection, 86 (2023), 1; 66-117 doi:10.1016/j.jinf.2022.10.030 (međunarodna recenzija, članak, znanstveni)
Marcec, R., Dodig, V. & Likic, R. (2023) Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?. Journal of Infection, 86 (1), 66-117 doi:10.1016/j.jinf.2022.10.030.
@article{article, author = {Marcec, Robert and Dodig, Vinko Michael and Likic, Robert}, year = {2023}, pages = {66-117}, DOI = {10.1016/j.jinf.2022.10.030}, keywords = {Regdanvimab, mortality, morbidity, COVID-19, }, journal = {Journal of Infection}, doi = {10.1016/j.jinf.2022.10.030}, volume = {86}, number = {1}, issn = {0163-4453}, title = {Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?}, keyword = {Regdanvimab, mortality, morbidity, COVID-19, } }
@article{article, author = {Marcec, Robert and Dodig, Vinko Michael and Likic, Robert}, year = {2023}, pages = {66-117}, DOI = {10.1016/j.jinf.2022.10.030}, keywords = {Regdanvimab, mortality, morbidity, COVID-19, }, journal = {Journal of Infection}, doi = {10.1016/j.jinf.2022.10.030}, volume = {86}, number = {1}, issn = {0163-4453}, title = {Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?}, keyword = {Regdanvimab, mortality, morbidity, COVID-19, } }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.